Work

Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists for resected stage IIB-IV melanoma.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.e15171

Authors: Sapna Pradyuman Patel, Gina R. Petroni, Elizabeth Mary Gaughan, William W. Grosh, Sacha Gnjatic, Patrick Hwu, Craig L. Slingluff

Institutions: The University of Texas MD Anderson Cancer Center, University of Virginia Health System, University of Virginia, Icahn School of Medicine at Mount Sinai

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890213178

Cites:

Cited by: 3

Related to: 20